ВНУТРИВЕННЫЙ ИММУНОГЛОБУЛИН В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ
Аннотация
Ключевые слова: новорожденные, внутривенный иммуноглобулин, аутоиммунные заболевания, первичный иммунодефицит.
(Вопросы современной педиатрии. – 2010;9(4):114-118)
Об авторах
А.Ю. ЩербинаРоссия
Т.Г. Косачева
Россия
А.Г. Румянцев
Россия
Список литературы
1. Imback P., Barandun S., díApuzzo V. et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet. 1981; 1: 1228–1131.
2. Bendtzen K., Hansen M.B., Ross C., Svenson M. High avidity autoantibodies to cytokines. Immunol Today. 1998; 19: 209–211.
3. Aukrust P., Froland S.S., Liabakk N.B. et al. Release of cytokines, soluble cytokine receptors, and interleukin 1 receptor antagonist after intravenous immunoglobulin administration in vivo. Blood. 1994; 84: 2136–2143.
4. Dalakas M.C. Intravenous immune globulin therapy for neurologic diseases. Ann. Intern. Med. 1997; 126: 721–730.
5. Clarkson S.B., Bussel J.B., Kimberly R.P. et al. Treatment of refractory immune thrombocytopenic purpura with an anti-Fc gamma-receptor antibody. N. Engl. J. Med. 1986; 314: 1236–1239.
6. Hahn A.F. Treatment of chronic inflammatory demyelinating polyneuropathy with intravenous immunoglobulin. Neurology. 1998; 51: 16–21.
7. Eijkhout H.W., van der Meer J.W.M., Kallenberg C.G.M. et al. The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. Ann. Intern. Med. 2001; 135: 165–174.
8. Olopoenia L., Young M., White D. et al. Intravenous immunoglobulin in symptomatic and asymptomatic children with perinatal HIV infection. J. Natl. Med. Assoc. 1997; 89: 543–547.
9. Molica S., Musto P., Chiurazzi F. et al. Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. Haematologica. 1996; 81: 121–126.
10. Sullivan K.M., Kopecky K.J., Jocom J. et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation. N. Engl. J. Med. 1990; 323: 705–712.
11. Stoll B.J., Gordon T., Korones S.B., et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. J. Pediatr. 1996; 129: 72–80.
12. Ohlsson A., Lacy J.B. Intravenous immunoglobulin for suspected or subsequently proven infection in neonates. Cochrane Database Syst Rev. 2004; (1): CD001239.
13. Ochs H.D., Pinciario P.J. Octagam® 5%, an intravenous IgG product, is efficacious and well tolerated in subjects with primary immunodeficiency diseases. J. Clin. Immun. 2004; 24(3): 309–314.
14. Debes A. Tolerability and safety of the intravenous immunoglobulin octagam: a 10-year prospective observational study. Pharmacoepidemiol Drug. Saf. 2007; 16(9): 1038–1047.
Рецензия
Для цитирования:
Щербина А., Косачева Т., Румянцев А. ВНУТРИВЕННЫЙ ИММУНОГЛОБУЛИН В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ. Вопросы современной педиатрии. 2010;9(4):114-118.
For citation:
Shcherbina A., Kosachyova T., Rumyantsev A. INTRAVENOUS IMMUNOGLOBULIN IN PEDIATRICS. Current Pediatrics. 2010;9(4):114-118.